BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11527133)

  • 1. Antiarrhythmic properties of beta-blockers.
    Haverkamp W; Hindricks G; Gülker H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers in arrhythmias].
    Fuhrer J
    Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers as antiarrhythmics drugs].
    Vasiljević-Pokrajcić ZM
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():39-43. PubMed ID: 18193809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III antiarrhythmic agents: the next wave.
    Bauman JL
    Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of myocardial infarction using anti-arrhythmia agents and beta-receptor blockers].
    Mösslacher H
    Acta Med Austriaca; 1984; 11(1):1-8. PubMed ID: 6143463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiarrhythmic therapy on mortality after myocardial infarction.
    Burckhardt D; Hoffmann A; Kiowski W; Pfisterer M; Burkart F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S77-81. PubMed ID: 1723124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
    Manning AS; Crome R; Isted K; Coltart DJ; Hearse DJ
    Adv Myocardiol; 1985; 6():515-28. PubMed ID: 2581300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of postoperative arrhythmias (author's transl)].
    Vormittag E
    Wien Klin Wochenschr; 1979 Apr; 91(8):267-71. PubMed ID: 88135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.